The platform also possesses dramatically lower manufacturing costs and higher scalability compared to typical antibody-based health solutions.
与典型的基于抗体的健康方案相比，该平台还拥有极低的生产成本以及较高的可测量性。
The platform also possesses dramatically lower manufacturing costs and higher scalability compared to typical antibody-based health solutions.
与典型的基于抗体的健康方案相比，该平台还拥有极低的生产成本以及较高的可测量性。
应用推荐